Advanced search×

Liver disease in pregnancy.

Postgrad Med J 86(1013):160-4 (2010) PMID 20237010

Pregnancy is a time of great maternal physiological and metabolic changes. This affects the biochemical and haematological parameters used in the assessment of liver disease, and it is important to appreciate the different reference ranges in pregnancy to facilitate recognition of liver disorders in pregnancy. Due to the increased physiological and metabolic stress of pregnancy, liver disorders that have previously been subclinical may become symptomatic-for example, primary biliary cirrhosis. Gallstone disease is a common problem in women of childbearing age, and pregnancy promotes their formation. The viral hepatidides constitute a huge disease burden worldwide and the pregnant state confers particular concerns for the mother and her baby. In particular, hepatitis E has a predilection for the pregnant population and confers a particularly poor prognosis. In addition certain pregnancy specific disorders-for example, haemolysis, elevated liver enzymes, low platelets syndrome, acute fatty liver of pregnancy, and obstetric cholestasis-affect primarily the liver. It is important to know how to diagnose and manage these conditions and distinguish them from non-pregnancy specific conditions as this will change the timing and management of affected women and their babies, some of whom can be seriously ill. We propose an approach to the investigation and management of the pregnant patient with abnormal liver function tests.

DOI: 10.1136/pgmj.2009.089631
Version: za2963e q8zae q8zb5 q8zcc q8zdb q8ze8 q8zf0 q8zge

Similar articles you may find interesting…

  1. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: A population based cohort study.

    Hepatology (2013) PMID 23564560

    We aimed to estimate the risk of developing hepatobiliary diseases in women with ICP and the odds of developing ICP in women with prevalent hepatobiliary diseases. We analyzed data of women with births between 1973 and 2009 and registered in the Swedish Medical Birth Register. By linkage with the Sw...
  2. Glycan Shifting on Hepatitis C Virus (HCV) E2 Glycoprotein is a Mechanism for Escape from Broadly Neutralizing Antibodies.

    J Mol Biol (2013) PMID 23458406

    We have generated potent HCV neutralizing antibodies hu5B3.v3 and MRCT10.v362 which, similar to the previously described AP33 and HCV1, bind to a highly conserved linear epitope on E2. We utilize a combination of in vitro resistance selections using the cell culture infectious HCV (HCVcc) and struct...
  3. Family planning and inflammatory bowel disease: the patient and the practitioner.

    (2013) PMID 22843639

    Background. Patients with inflammatory bowel disease (IBD) are commonly in their child-bearing years. Maintainance medication, as recommended by international guidelines, is an emotive topic and an anxiety source. This study measures the awareness of patients and primary practitioner...